按术后即刻心肌梗死溶栓试验(Thrombolysis In Myocardial Infarction,TIMI)血流分级将病人分为2组:正常复流组(138例)和无复流组(52例),比较两组患者的基本临床资料、实验室检查结果及PCI术中靶病变及...
基于55个网页-相关网页
与传统造模方法相比,评判造模前后的冠状动脉造影血流分级(Thrombolysis in Myocardial Infarction,TIMI)评分、管腔内径,血管内膜厚度和泡沫细胞阳性面积的变化,以及血凝血酶原时间(Prothrombin T...
基于8个网页-相关网页
结果:替罗非班组于术前应用盐酸替罗非班使PCI前梗死相关血管心肌梗死溶栓治疗(thrombolysis in myocardial infarction,TIMI)血流分级提高,替罗非班组达1级、2级血流者比例分别高于对照组(均P<0·01),对照组完全闭塞比率明...
基于8个网页-相关网页
thrombolysis in myocardial infarction trial 心肌梗死溶栓治疗试验 ; 试验 ; 心肌梗死溶栓试验
Thrombolysis in Myocardial Infarction Flow 单变量和多变量分析
thrombolysis in acute myocardial infarction 灌注分级 ; 准确判断血流灌注分级
Results of coronary angiography, clinical effect and thrombolysis in myocardial infarction trial (TIMI) of the two groups were compared and analyzed.
比较两组造影结果、临床预后及心肌梗塞溶栓(TIMI)血流分级。
Objective: To study the efficacy and safety with thrombolysis of urokinase produced in China on acute myocardial infarction.
目的：评价国产尿激酶在急性心肌梗死溶栓治疗中的有效性和安全性。
Objectives to investigate the clinical features in type 2 diabetic patients with acute myocardial infarction (AMI) and to assess the therapeutic effects of intravenous thrombolysis.
目的探讨2型糖尿病并发急性心肌梗死的临床特征与静脉溶栓的疗效。
应用推荐